Lallemand Pharma

News details


Lallemand Pharma and Stada Cis Join forces to launch Ismigen in Russia

Nov 13, 2014

LALLEMAND PHARMA and STADA CIS are pleased to announce the launch on the Russian market of PMBL™ tablets, an immuno-modulating drug developed and produced by Lallemand Pharma and distributed in Russia by STADA CIS under tradename ISMIGEN®. ISMIGEN®is recommended in the prevention of acute, sub-acute, recurrent or chronic infections of the upper and lower airways and the bronchopulmonary tree in adults and children.